Join
Live feed
·
SECFilingvia Quantisnow
Eikon Therapeutics Inc. logo

Amendment: SEC Form SCHEDULE 13G/A filed by Eikon Therapeutics Inc.

ByQuantisnow·Wall Street's wire, on your screen.
EIKN· Eikon Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EIKN (Eikon Therapeutics Inc.) and more on Quantisnow.